http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103694375-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 |
| filingDate | 2013-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103694375-B |
| titleOfInvention | A kind of triterpene-cyclodextcovalent covalent compound and its production and use |
| abstract | The invention provides the triterpene cyclodextrin covalent compound shown in formula (I) or its stereoisomer, epimer or configurational isomer, or described triterpene cyclodextrin covalent compound or the pharmaceutically acceptable salt of its stereoisomer, epimer or configurational isomer or ester, or described triterpene cyclodextrin covalent compound or its stereoisomer, epimer or configurational isomer or its pharmaceutically acceptable salt or the hydrate of ester, wherein, R T Shown in formula (II), n therein, dotted portion, R 1 ～R 9 、R 15 ～R 17 、R C 、R C’ Definition as noted in the discussion.Additionally provide and prepare above-mentioned triterpene cyclodextrin covalent compound or its pharmaceutically acceptable salt or the method for their hydrate, and the application that above-claimed cpd is in preparing the medicine for preventing or treat influenza or hepatitis C. |
| priorityDate | 2013-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 514.